Yi Jirong, Marcinkiewicz Anna M, Shanbhag Aakash, Miller Robert J H, Geers Jolien, Zhang Wenhao, Killekar Aditya, Manral Nipun, Lemley Mark, Buchwald Mikolaj, Kwiecinski Jacek, Zhou Jianhang, Kavanagh Paul B, Liang Joanna X, Builoff Valerie, Ruddy Terrence D, Einstein Andrew J, Feher Attila, Miller Edward J, Sinusas Albert J, Berman Daniel S, Dey Damini, Slomka Piotr J
Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Departments of Medicine (Division of Artificial Intelligence in Medicine), Biomedical Sciences, and Imaging, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Center of Radiological Diagnostics, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland.
Lancet Digit Health. 2025 May 12:100862. doi: 10.1016/j.landig.2025.02.002.
CT attenuation correction (CTAC) scans are routinely obtained during cardiac perfusion imaging, but currently only used for attenuation correction and visual calcium estimation. We aimed to develop a novel artificial intelligence (AI)-based approach to obtain volumetric measurements of chest body composition from CTAC scans and to evaluate these measures for all-cause mortality risk stratification.
We applied AI-based segmentation and image-processing techniques on CTAC scans from a large international image-based registry at four sites (Yale University, University of Calgary, Columbia University, and University of Ottawa), to define the chest rib cage and multiple tissues. Volumetric measures of bone, skeletal muscle, subcutaneous adipose tissue, intramuscular adipose tissue (IMAT), visceral adipose tissue (VAT), and epicardial adipose tissue (EAT) were quantified between automatically identified T5 and T11 vertebrae. The independent prognostic value of volumetric attenuation and indexed volumes were evaluated for predicting all-cause mortality, adjusting for established risk factors and 18 other body composition measures via Cox regression models and Kaplan-Meier curves.
The end-to-end processing time was less than 2 min per scan with no user interaction. Between 2009 and 2021, we included 11 305 participants from four sites participating in the REFINE SPECT registry, who underwent single-photon emission computed tomography cardiac scans. After excluding patients who had incomplete T5-T11 scan coverage, missing clinical data, or who had been used for EAT model training, the final study group comprised 9918 patients. 5451 (55%) of 9918 participants were male and 4467 (45%) of 9918 participants were female. Median follow-up time was 2·48 years (IQR 1·46-3·65), during which 610 (6%) patients died. High VAT, EAT, and IMAT attenuation were associated with an increased all-cause mortality risk (adjusted hazard ratio 2·39, 95% CI 1·92-2·96; p<0·0001, 1·55, 1·26-1·90; p<0·0001, and 1·30, 1·06-1·60; p=0·012, respectively). Patients with high bone attenuation were at reduced risk of death (0·77, 0·62-0·95; p=0·016). Likewise, high skeletal muscle volume index was associated with a reduced risk of death (0·56, 0·44-0·71; p<0·0001).
CTAC scans obtained routinely during cardiac perfusion imaging contain important volumetric body composition biomarkers that can be automatically measured and offer important additional prognostic value.
The National Heart, Lung, and Blood Institute, National Institutes of Health.
心脏灌注成像时通常会进行CT衰减校正(CTAC)扫描,但目前仅用于衰减校正和可视钙评估。我们旨在开发一种基于人工智能(AI)的新方法,从CTAC扫描中获取胸部身体成分的体积测量值,并评估这些测量值用于全因死亡风险分层的情况。
我们对来自四个地点(耶鲁大学、卡尔加里大学、哥伦比亚大学和渥太华大学)的一个大型国际影像登记处的CTAC扫描应用基于AI的分割和图像处理技术,以定义胸部肋骨和多种组织。在自动识别的T5和T11椎体之间对骨骼、骨骼肌、皮下脂肪组织、肌内脂肪组织(IMAT)、内脏脂肪组织(VAT)和心外膜脂肪组织(EAT)的体积测量值进行量化。通过Cox回归模型和Kaplan-Meier曲线,在调整既定风险因素和其他18种身体成分测量值后,评估体积衰减和指数化体积对预测全因死亡的独立预后价值。
每次扫描的端到端处理时间少于2分钟,无需用户干预。在2009年至2021年期间,我们纳入了来自四个参与REFINE SPECT登记处的11305名参与者,他们接受了单光子发射计算机断层扫描心脏扫描。在排除T5 - T11扫描覆盖不完整、临床数据缺失或已用于EAT模型训练的患者后,最终研究组包括9918名患者。9918名参与者中5451名(55%)为男性,4467名(45%)为女性。中位随访时间为2.48年(IQR 1.46 - 3.65),在此期间610名(6%)患者死亡。高VAT、EAT和IMAT衰减与全因死亡风险增加相关(调整后的风险比分别为2.39,95%CI 1.92 - 2.96;p<0.0001,1.55,1.26 - 1.90;p<0.0001,以及1.30,1.06 - 1.60;p = 0.012)。高骨衰减患者的死亡风险降低(0.77,0.62 - 0.95;p = 0.016)。同样,高骨骼肌体积指数与死亡风险降低相关(0.56,0.44 - 0.71;p<0.0001)。
心脏灌注成像时常规获得的CTAC扫描包含重要的体积身体成分生物标志物,这些标志物可自动测量并提供重要的额外预后价值。
美国国立卫生研究院国家心肺血液研究所。